Ethoxzolamide
Jump to navigation
Jump to search
| File:Ethoxzolamide structure.svg | |
| Gene therapy | |
|---|---|
| Clinical data | |
| Physiological data | |
| Legal status | |
| Pharmacokinetic data | |
| Protein binding | ~89% |
| Elimination half-life | 2.5-5.5 hours |
| Identifiers | |
| |
| CAS Number | |
| PubChem Template:Abbreviation | |
| DrugBank | |
| Chemical and physical data | |
| Formula | C9H10N2O3S2 |
| Molar mass | 258.319 g/mol |
Ethoxzolamide (alternatively known as Ethoxyzolamide) is a sulfonamide medication that functions as a carbonic anhydrase inhibitor. It is used in the treatment of glaucoma, duodenal ulcers, and as a diuretic. It may also be used in the treatment of some forms of epilepsy.
Brand names include Cardrase®, Diuretic C®, Ethamide®, Glaucotensil®, and Redupresin®.
Categories:
- Articles with short description
- Pages with broken file links
- Infobox-drug molecular-weight unexpected-character
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Anticonvulsants
- Sulfonamides
- Benzothiazoles